Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the ...
By leveraging advanced Polymerase Chain Reaction (PCR) technology with streamlined testing for a broad ... cause of diarrheal illness and helping reduce unnecessary antibiotic use iii. The panel also ...
The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...
Closing rural diagnostic gap, HealthTrackRx delivers next-morning PCR test results nationwide to improve infection diagnosis and treatment.
3d
A scalpel that can diagnose? Scientists unveil a 'Lab-on-a-Scalpel' for real-time surgical insights
Imagine a surgeon in the middle of a complex operation, able to get instant biochemical feedback not from a lab down the hall ...
Natural spiderwebs are good at capturing DNA from the environment, but artificial webs are cheap and provide better control – ...
Molbio Diagnostics, an innovative point-of-care diagnostics company, has been awarded the KOCHON Prize 2024 by the Stop TB ...
The United States Tumor Profiling Market is projected to surge from US$ 3.41 billion in 2024 to US$ 7.44 billion by 2033, ...
State Key Laboratory for Quality and Safety of Agro-Products, Key Laboratory of Biotechnology in Plant Protection of MARA, Zhejiang Key Laboratory of Green Plant Protection, Institute of Plant ...
Amcor has published its fiscal 2025 Sustainability Report, confirming it met its global target of using 10% PCR plastic by ...
Investing.com -- Co-Diagnostics Inc (NASDAQ:CODX) stock surged 100% on Monday after the molecular diagnostics company announced a definitive agreement to form a joint venture in Saudi Arabia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback